Coronavirus Notebook: UK Ups Vaccine Efforts & Calls For More Candidate Therapies
China Issues Vaccine Guidelines, Russia Talks Trials With Saudis
The UK has been stepping up its COVID-19 activity in recent days, ordering more vaccines, encouraging more volunteers to join clinical trials, and expanding its RECOVERY platform for potential new coronavirus therapies. But the government's sudden decision to replace Public Health England with a new institute has raised some concerns within the biopharma industry.
You may also be interested in...
Russia may have approved the first COVID-19 vaccine, but there is uncertainty over when immunization will begin, who will receive it first, and whether the Russian authorities are planning to carry out Phase III trials.
The agreement will give all EU member states the option to access the drug major's investigational COVID-19 vaccine dubbed AZD1222 "in an equitable manner at no profit during the pandemic."
China has shown willingness to go tit-for-tat in its bilateral disputes with the US and the latest comments from US officials show an underlying distrust over clinical data and vaccines safety in China, raising fresh concerns just when collaboration is needed to accelerate availability of the first vaccines in the global pandemic.